Latest FDA Warning Letters Highlight Aseptic Processing Issues
This article was originally published in The Gold Sheet
Executive Summary
A number of recent FDA warning letters focused on GMP issues with aseptic processing, signaling the agency’s continuing concern about contamination prevention.